Ensign Peak Advisors
GMED icon

Ensign Peak Advisors’s Globus Medical GMED Stock Holding History

Ensign Peak Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$498K Hold
6,308
– – ﹤0.01% 987
2026
Q1 		$543K Hold
6,308
– – ﹤0.01% 939
2025
Q4 		$551K Sell
6,308
-18,445
-75% -$1.4M ﹤0.01% 937
2025
Q3 		$1.42M Sell
24,753
-43,715
-64% -$2.52M ﹤0.01% 903
2025
Q2 		$4.04M Buy
68,468
+230
+0.3% +$14.9K 0.01% 688
2025
Q1 		$5M Buy
68,238
+7,591
+13% +$627K 0.01% 635
2024
Q4 		$5.02M Buy
60,647
+24,289
+67% +$1.92M 0.01% 646
2024
Q3 		$2.6M Hold
36,358
– – ﹤0.01% 838
2024
Q2 		$2.49M Hold
36,358
– – ﹤0.01% 827
2024
Q1 		$1.95M Buy
36,358
+4,366
+14% +$235K ﹤0.01% 935
2023
Q4 		$1.7M Buy
31,992
+10,700
+50% +$521K ﹤0.01% 993
2023
Q3 		$1.06M Hold
21,292
– – ﹤0.01% 1158
2023
Q2 		$1.27M Hold
21,292
– – ﹤0.01% 1079
2023
Q1 		$1.21M Hold
21,292
– – ﹤0.01% 1092
2022
Q4 		$1.58M Sell
21,292
-5,300
-20% -$361K ﹤0.01% 900
2022
Q3 		$1.58M Sell
26,592
-420
-2% -$25.3K ﹤0.01% 862
2022
Q2 		$1.52M Hold
27,012
– – ﹤0.01% 929
2022
Q1 		$1.99M Sell
27,012
-1,855
-6% -$129K ﹤0.01% 890
2021
Q4 		$2.08M Sell
28,867
-43,325
-60% -$3.15M ﹤0.01% 937
2021
Q3 		$5.53M Buy
72,192
+5,500
+8% +$442K 0.01% 613
2021
Q2 		$5.17M Buy
66,692
+3,335
+5% +$237K 0.01% 638
2021
Q1 		$3.91M Sell
63,357
-16,015
-20% -$1.01M 0.01% 735
2020
Q4 		$5.18M Sell
79,372
-1,160
-1% -$66.7K 0.01% 598
2020
Q3 		$3.99M Hold
80,532
– – 0.01% 694
2020
Q2 		$3.84M Hold
80,532
– – 0.01% 695
2020
Q1 		$3.42M Buy
80,532
+23,310
+41% +$1.15M 0.01% 619
2019
Q4 		$3.37M Buy
+57,222
New +$3.11M 0.01% 787

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ensign Peak Advisors's GMED Position: Q2 2026 in Review

Ensign Peak Advisors held its Globus Medical (GMED) position steady in Q2 2026 at 6,308 shares worth $498K. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Ensign Peak Advisors first reported a position in GMED in Q4 2019 and has held it in 27 quarters since. The position peaked at $5.53M in Q3 2021. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Ensign Peak Advisors held 6,308 shares of Globus Medical worth $498K as of Q2 2026.
  • Ensign Peak Advisors left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #987 holding.
  • Ensign Peak Advisors first reported a position in Globus Medical in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Globus Medical position peaked at $5.53M in Q3 2021.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.